BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 25413223)

  • 1. Carvedilol and nebivolol improve left ventricular systolic functions in patients with non-ischemic heart failure.
    Karabacak M; Doğan A; Tayyar Ş; Özaydın M; Erdoğan D
    Anatol J Cardiol; 2015 Apr; 15(4):271-6. PubMed ID: 25413223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function.
    Lombardo RM; Reina C; Abrignani MG; Rizzo PA; Braschi A; De Castro S
    Am J Cardiovasc Drugs; 2006; 6(4):259-63. PubMed ID: 16913827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of nebivolol and carvedilol on left ventricular diastolic function in older heart failure patients with preserved ejection fraction: study protocol for a randomized controlled trial.
    Park K; Park TH
    Trials; 2016 Nov; 17(1):530. PubMed ID: 27809882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of carvedilol and nebivolol on diastolic functions of the left ventricle in patients with non-ischemic heart failure.
    Dogan A; Karabacak M; Tayyar S; Erdogan D; Ozaydin M
    Cardiol J; 2014; 21(1):76-82. PubMed ID: 23799553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC).
    Bergström A; Andersson B; Edner M; Nylander E; Persson H; Dahlström U
    Eur J Heart Fail; 2004 Jun; 6(4):453-61. PubMed ID: 15182771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of carvedilol and nebivolol on oxidative stress status in patients with non-ischaemic heart failure.
    Karabacak M; Dogan A; Tayyar S; Bas HA
    Kardiol Pol; 2015; 73(3):201-6. PubMed ID: 25299401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure.
    Palazzuoli A; Quatrini I; Vecchiato L; Scali C; De Paola V; Iovine F; Martini G; Nuti R
    Minerva Cardioangiol; 2005 Aug; 53(4):321-8. PubMed ID: 16177676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
    Duygu H; Turk U; Ozdogan O; Akyuz S; Kirilmaz B; Alioglu E; Gunduz R; Bozkaya YT; Turkoglu C; Payzin S
    Cardiovasc Ther; 2008; 26(3):182-8. PubMed ID: 18786088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative long term effects of nebivolol and carvedilol in hypertensive heart failure patients.
    Marazzi G; Volterrani M; Caminiti G; Iaia L; Massaro R; Vitale C; Sposato B; Mercuro G; Rosano G
    J Card Fail; 2011 Sep; 17(9):703-9. PubMed ID: 21872138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment.
    Paraskevaidis I; Farmakis D; Parissis JT; Dodouras T; Filippatos G; Tsiapras D; Kremastinos DT
    J Card Fail; 2007 Mar; 13(2):108-13. PubMed ID: 17395050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A failed improvement in pulmonary function and exercise capacity with carvedilol in congestive heart failure despite an excellent effect on left ventricular function].
    Guazzi M; Pontone G; Trevisi N; Lomanto M; Matturri M; Agostoni P
    Cardiologia; 1998 Feb; 43(2):181-7. PubMed ID: 9557374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
    J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carvedilol improves functional class in patients with severe left ventricular dysfunction referred for heart transplantation.
    Pamboukian SV; Aminbakhsh A; Thompson CR; Amin H; Mortimer S; D'yachkova Y; Ignaszweski AP
    Clin Transplant; 1999 Oct; 13(5):426-31. PubMed ID: 10515224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure.
    Metra M; Covolo L; Pezzali N; Zacà V; Bugatti S; Lombardi C; Bettari L; Romeo A; Gelatti U; Giubbini R; Donato F; Dei Cas L
    Cardiovasc Drugs Ther; 2010 Feb; 24(1):49-60. PubMed ID: 20352314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure.
    Palazzuoli A; Bruni F; Puccetti L; Pastorelli M; Angori P; Pasqui AL; Auteri A
    Eur J Heart Fail; 2002 Dec; 4(6):765-70. PubMed ID: 12453548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of nebivolol versus carvedilol on left ventricular function and exercise capacity in patients with nonischemic dilated cardiomyopathy. A 12-month study.
    Patrianakos AP; Parthenakis FI; Mavrakis HE; Diakakis GF; Chlouverakis GI; Vardas PE
    Am Heart J; 2005 Nov; 150(5):985. PubMed ID: 16290981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of carvedilol on left ventricular regional wall motion in patients with heart failure caused by ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Doughty RN; Whalley GA; Gamble G; MacMahon S; Sharpe N
    J Card Fail; 2000 Mar; 6(1):11-8. PubMed ID: 10746814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular diastolic function improvement by carvedilol therapy in advanced heart failure.
    Palazzuoli A; Quatrini I; Vecchiato L; Calabria P; Gennari L; Martini G; Nuti R
    J Cardiovasc Pharmacol; 2005 Jun; 45(6):563-8. PubMed ID: 15897784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy.
    Ghio S; Magrini G; Serio A; Klersy C; Fucili A; Ronaszèki A; Karpati P; Mordenti G; Capriati A; Poole-Wilson PA; Tavazzi L;
    Eur Heart J; 2006 Mar; 27(5):562-8. PubMed ID: 16443607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial contractile reserve under low doses of dobutamine and improvement of left ventricular ejection fraction with treatment by carvedilol.
    Jourdain P; Funck F; Fulla Y; Hagege A; Bellorini M; Guillard N; Loiret J; Thebault B; Desnos M
    Eur J Heart Fail; 2002 Jun; 4(3):269-76. PubMed ID: 12034151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.